Match4Health 2024

20–21 Sept 2024 | Larissa, Greece

ServiceUpdated on 18 July 2024

Maltese biotech company offers microbiology testing services internationally to the pharmaceutical and cosmetics industry.

Alexia Pace Kiomall

EEN Manager - R&I at Malta Enterprise

San Gwann, Malta

About

The Maltese company offers an extensive array of services that encompasses a wide spectrum of microbiological tests, including bioburden studies, microbial limits, and microorganism identification using DNA sequencing. The company tests an array of materials, spanning raw materials, excipients, active pharmaceutical ingredients (APIs), and finished products (non-sterile products). The state-of-the-art laboratory is fitted with the best equipment and facilities ensuring a contaminant-free environment. It aims to develop and validate analytical methods tailor made for clients. It employs advanced next-generation sequencing techniques for microorganism identification and delivers a level of sensitivity and reliability that exceeds conventional methods.

The company is mainly seeking pharmaceutical and cosmetic companies that require precise identification of microorganisms at the species level to assess the source and severity of the contamination.

Type

  • Women’s health & FemTech

Applies to

  • Biotech and Lifescience

Organisation

Malta Enterprise

Public Body

San Gwann, Malta

Similar opportunities